BITA [BITAUTO] 6-K: (Original Filing)

[Bitauto Announces First Quarter 2020 Results [1] BEIJING, June 12, 2020 /PRNewswire/ -- Bitauto Holdings Limited ("Bitauto" or the "Company") (NYSE: BITA), a leading provider of internet content & marketing services, and transaction services for China's automotive industry, today announced its unaud]

CHL [CHINA MOBILE] 6-K: (Original Filing)

[Number 1.1 Announcement with respect to Grant of Share Options Under the Share Option Scheme, dated June 12, 2020 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network]

CHNR [CHINA NATURAL RESOURCES] 20-F/A: (Original Filing)

[] [CERTIFICATION I, Wong Wah On Edward, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of China Natural Resources, Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necess]

By | 2020-10-01T15:01:12+00:00 June 15th, 2020|Categories: Chinese Stocks, CHNR, SEC Original|Tags: , , , , , |0 Comments

SPU [Future FinTech] 8-K: (Original Filing)

[EXCHANGE AGREEMENT Agreement Lender Borrower This Exchange Agreement (this “ Original Note Purchase Agreement Transaction Documents A. Borrower previously sold and issued to Lender that certain Secured Convertible Promissory Note dated March 26, 2019 in the original principal amount of $1,070,000.00]

By | 2020-10-01T09:49:02+00:00 June 15th, 2020|Categories: Chinese Stocks, SEC Original, SPU|Tags: , , , , , |0 Comments

BITA [BITAUTO] 6-K: (Original Filing)

[] [Execution Version AGREEMENT AND PLAN OF MERGER yiche holding limited BITAUTO HOLDINGS LIMITED TABLE OF CONTENTS Page Article I DEFINITIONS AND INTERPRETATION 2 Section 1.1 Certain Definitions 2 Section 1.2 Terms Defined Elsewhere 11 Section 1.3 Interpretation 13 Article II THE MERGER 15 Section 2]

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]

By | 2020-10-01T15:38:07+00:00 June 15th, 2020|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Skip to toolbar